1.
|
Phase: Phase III Type: Prevention Status: Active Age: 40 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: COLO CP-01-US, NCT00486512
|
|
2.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UMN-2005NT018, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 18 Sponsor: NCI Protocol IDs: CCCWFU-85106, CCCWFU-IRB00000371, CCCWFU 85106, NCT00499408
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-I-95406, I 95406, NCT00524680
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 30 to 85 Sponsor: Other Protocol IDs: M2140, NCT00741364
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-0580-B, NCT00744549
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-0604-CE, NCT00844792
|
|
8.
|
Phase: Phase II Type: Prevention Status: Active Age: 21 and over Sponsor: Other Protocol IDs: Protocol Dated 121308, AAAD3638, NCT00859651
|
|
9.
|
Phase: Phase II Type: Prevention Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11548, NCT00867217
|
|
10.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 50 and over Sponsor: NCI Protocol IDs: NU-08I3, NU 08I3, NCT00870961
|
|
11.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SUNY UMU IRB # 4689, NCT00145704
|
|
12.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-I-128308, I 128308, NCT00887432
|